ArticleDrug design, development and therapy2025

Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of

Juan Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.